Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.

[1]  A. Zanchetti,et al.  Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial , 2008, Journal of hypertension.

[2]  B. Gersh,et al.  Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[3]  J. Camm,et al.  Is there any hope for angiotensin-converting enzyme inhibitors in atrial fibrillation? , 2007, American heart journal.

[4]  J. Le Heuzey,et al.  Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. , 2007, European heart journal.

[5]  S. Mohiuddin,et al.  Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. , 2006, American heart journal.

[6]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[7]  J. Seward,et al.  Effects of quinapril on left atrial structural remodeling and arterial stiffness. , 2006, The American journal of cardiology.

[8]  A. Waldo.  Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study , 2006 .

[9]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[10]  R. Page.  Newly Diagnosed Atrial Fibrillation , 2004 .

[11]  A. Reiner,et al.  Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. , 2004, JAMA.

[12]  R. Page.  Clinical practice. Newly diagnosed atrial fibrillation. , 2004, The New England journal of medicine.

[13]  K. Arakawa,et al.  Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[14]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[15]  Maurizio Bentivoglio,et al.  Atrial Fibrillation in Hypertension: Predictors and Outcome , 2003, Hypertension.

[16]  B. Psaty,et al.  Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal ischemic stroke in postmenopausal women. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[17]  A. Stergachis,et al.  Group Health Cooperative of Puget Sound , 2002 .

[18]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[19]  P. Kowey,et al.  Management and prevention of atrial fibrillation after cardiovascular surgery. , 2000, The American journal of cardiology.

[20]  T. Hedner,et al.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.

[21]  L. Niskanen,et al.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.

[22]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[23]  T. Raghunathan,et al.  The risk of myocardial infarction associated with antihypertensive drug therapies. , 1995, JAMA.

[24]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[25]  D. Levy,et al.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. , 1994, JAMA.

[26]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .